The first Gracell Biotechnologies trade was made in Q1 2022.
Since then Jim Simons bought shares three more times and sold shares on five occasions. The investor completely sold their stake between Q3 2023 and Q1 2024.
Avg closing price
Price range
Sold -39.3k shares
Q1 2024
Avg closing price
$10.13
Price range
$9.99
-
$10.35
Sold 15.7% shares (-7.3k shares)
Q4 2023
Avg closing price
$4.54
Price range
$2.43
-
$10.04
Sold 5.1% shares (-2.5k shares)
Q3 2023
Avg closing price
$3.66
Price range
$2.83
-
$4.90
Increased shares by 0.4% (+200 shares)
Q2 2023
Avg closing price
$2.80
Price range
$1.45
-
$6.07
Sold 0.2% shares (-100 shares)
Q1 2023
Avg closing price
$2.09
Price range
$1.80
-
$2.50
Sold 2.6% shares (-1.3k shares)
Q4 2022
Avg closing price
$3.06
Price range
$2.08
-
$3.96
Increased shares by 0.8% (+400 shares)
Q3 2022
Avg closing price
$3.25
Price range
$2.08
-
$5.15
Increased shares by 111.4% (+26.3k shares)
Q2 2022